|LivaNova to Host Conference Call for Second Quarter 2018 Results|
A live webcast of the conference call will be available on the Investor
Relations section of LivaNova’s website at www.livanova.com.
To listen to the conference call by telephone, dial 866-393-4306 (if
dialing from within the U.S.) or 734-385-2616 (if dialing from outside
the U.S.). The conference ID is 5184037. Listeners should log on
approximately 10 minutes in advance to ensure proper setup to receive
the webcast. A replay will be available on the
LivaNova PLC is a global medical technology company built on nearly five
decades of experience and a relentless commitment to improve the lives
of patients around the world. LivaNova’s advanced technologies and
breakthrough treatments provide meaningful solutions for the benefit of
patients, healthcare professionals and healthcare systems. Headquartered
in London, LivaNova has a presence in more than 100 countries worldwide.
The Company currently employs more than 3,500 employees.
LivaNova operates as two businesses: Cardiac Surgery and
Neuromodulation, with operating headquarters in Mirandola (
Safe Harbor Statement
This news release contains forward-looking statements within the meaning
of Section 27A of the United States Securities Act of 1933, as amended,
and Section 21E of the United States Securities Exchange Act of 1934, as
amended. Forward-looking statements are not historical facts but are
based on certain assumptions of management and describe LivaNova’s
future plans, strategies and expectations. Forward-looking statements
can generally be identified by the use of forward-looking terminology,
including, but not limited to, "may," “could,” “seek,” “guidance,”
“predict,” “potential,” “likely,” "believe," "will," "expect,"
"anticipate," "estimate," "plan," "intend," "forecast," or variations of
these terms and similar expressions, or the negative of these terms or
similar expressions. Forward-looking statements contained in this news
release are based on information presently available to
All information in this news release is as of the date of its release.
LivaNova PLC Investor Relations and Media